{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:37:17Z","timestamp":1793943437828,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ymthe.2023.07.020","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T21:13:48Z","timestamp":1690492428000},"page":"2999-3014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-9663","authenticated-orcid":false,"given":"Eloise","family":"Hudry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Meseck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis Fonyuy","family":"Tukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley","family":"Penraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.07.020_bib1","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.3390\/ijms22147647","article-title":"Gene therapy in hemophilia: recent advances","volume":"22","author":"Rodr\u00edguez-Merch\u00e1n","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2023.07.020_bib3","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41587-020-0642-9","article-title":"High-dose AAV gene therapy deaths","volume":"38","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2020.11.001","article-title":"Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy","volume":"74","author":"Chand","year":"2021","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib5","doi-asserted-by":"crossref","first-page":"675897","DOI":"10.3389\/fimmu.2021.675897","article-title":"Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes","volume":"12","author":"Hamilton","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2023.07.020_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JND-221560","article-title":"Intrathecal onasemnogene abeparvovec for sitting, nonambulatory patients with spinal muscular atrophy: Phase I ascending-dose study (STRONG)","volume":"10","author":"Finkel","year":"2023","journal-title":"J.\u00a0Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2023.07.020_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/01926233221101309","article-title":"Intrathecal sc-AAV9-CB-GFP: Systemic distribution predominates following single-dose administration in cynomolgus macaques","volume":"50","author":"Meseck","year":"2022","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.suc.2010.04.017","article-title":"Liver anatomy","volume":"90","author":"Abdel-Misih","year":"2010","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.ymthe.2023.07.020_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/j.2040-4603.2013.tb00503.x","article-title":"Liver immunology","volume":"3","author":"Bogdanos","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver \u2014 from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/cmi.2015.97","article-title":"Hepatocytes: a key cell type for innate immunity","volume":"13","author":"Zhou","year":"2016","journal-title":"Cel. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib14","doi-asserted-by":"crossref","first-page":"103728","DOI":"10.1016\/j.cellimm.2017.12.002","article-title":"Liver induced transgene tolerance with AAV vectors","volume":"342","author":"Keeler","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U","article-title":"Cytokines and the hepatic acute phase response","volume":"181","author":"Moshage","year":"1997","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.07.020_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nm1549","article-title":"CD8(+) T-cell responses to adeno-associated virus capsid in humans","volume":"13","author":"Mingozzi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.07.020_bib18","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.07.020_bib19","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.07.020_bib20","doi-asserted-by":"crossref","first-page":"666666","DOI":"10.3389\/fimmu.2021.666666","article-title":"T Cell-mediated immune responses to AAV and AAV vectors","volume":"12","author":"Ertl","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib21","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/mt.2011.81","article-title":"Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates","volume":"19","author":"Li","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.020_bib22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ymthe.2017.02.014","article-title":"The Balance between CD8(+) T\u00a0cell-mediated clearance of AAV-encoded antigen in the liver and tolerance is dependent on the vector dose","volume":"25","author":"Kumar","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.020_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/hum.2020.182","article-title":"Moving forward after two deaths in a gene therapy trial of myotubular myopathy","volume":"31","author":"Wilson","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2023.07.020_bib24","first-page":"292","article-title":"Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression","volume":"24","author":"Wang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.020_bib25","article-title":"CANaspire, a first-in-human phase 1\/2 controlled open-label study of BBP-812, a recombinant AAV9-hASPA vector for the treatment of Canavan disease","author":"Eichler","year":"2022","journal-title":"Poster Presented Child Neurol. Soc. Annu. Meet."},{"key":"10.1016\/j.ymthe.2023.07.020_bib26","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1172\/JCI37607","article-title":"The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice","volume":"119","author":"Zhu","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.07.020_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2020.00354","article-title":"Systemic MCP-1 levels derive mainly from injured liver and are associated with complications in cirrhosis","volume":"11","author":"Queck","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fphys.2012.00213","article-title":"The role of chemokines in acute liver injury","volume":"3","author":"Saiman","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib29","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/JVI.76.9.4580-4590.2002","article-title":"Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors","volume":"76","author":"Zaiss","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib30","first-page":"23","article-title":"Characterization of acute toxicity after high-dose systemic adeno-associated virus in nonhuman primates, including impact of vector characteristics","volume":"29","author":"Hordeaux","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.07.020_bib31","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The neurotropic properties of AAV-PHP.B are limited to C57BL\/6J Mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.020_bib32","author":"Wilson"},{"key":"10.1016\/j.ymthe.2023.07.020_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/hum.2021.116","article-title":"Biodistribution and tolerability of AAV-PHP.B-CBh-SMN1 in Wistar Han rats and cynomolgus macaques reveal different toxicologic profiles","volume":"33","author":"Palazzi","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2023.07.020_bib34","doi-asserted-by":"crossref","first-page":"991832","DOI":"10.3389\/fimmu.2022.991832","article-title":"A versatile toolkit for overcoming AAV immunity","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib35","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1708538","article-title":"Hemophilia B gene therapy with a high-specific-activity factor IX variant","volume":"377","author":"George","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.07.020_bib36","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.28944","article-title":"Pediatric acute liver failure of undetermined cause: A research workshop","volume":"65","author":"Alonso","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2023.07.020_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0022-2836(87)90689-9","article-title":"CpG islands in vertebrate genomes","volume":"196","author":"Gardiner-Garden","year":"1987","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ymthe.2023.07.020_bib38","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2144\/00286ir01","article-title":"The Sequence Manipulation Suite: JavaScript programs for analyzing and formatting protein and DNA sequences","volume":"28","author":"Stothard","year":"2000","journal-title":"Biotechniques"},{"key":"10.1016\/j.ymthe.2023.07.020_bib39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/0192623318761348","article-title":"Use of Severity grades to characterize histopathologic changes","volume":"46","author":"Schafer","year":"2018","journal-title":"Toxicol. Pathol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162300401X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162300401X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:11:00Z","timestamp":1761502260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162300401X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S152500162300401X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.020","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}